| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Antonio Clavenna, Maurizio Bonat. Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD. Expert opinion on drug safety. vol 16. issue 12. 2017-11-17. PMID:28984477. |
stimulant (methylphenidate, amphetamines) and non stimulant (atomoxetine, clonidine and guanfacine) are the treatment usually prescribed for adhd. |
2017-11-17 |
2023-08-13 |
Not clear |
| Ryan C W Hall, Wade C Myer. Challenges and Limitations to Treating ADHD in Incarcerated Populations. The journal of the American Academy of Psychiatry and the Law. vol 44. issue 2. 2017-08-21. PMID:27236170. |
although there are many effective psychopharmacologic treatments for adhd, such as various formulations of amphetamines, many physicians are hesitant to prescribe controlled stimulants in correctional settings because of concerns about abuse and safety. |
2017-08-21 |
2023-08-13 |
Not clear |
| Salima Punja, Christopher H Schmid, Lisa Hartling, Liana Urichuk, Catherine Jane Nikles, Sunita Vohr. To meta-analyze or not to meta-analyze? A combined meta-analysis of N-of-1 trial data with RCT data on amphetamines and methylphenidate for pediatric ADHD. Journal of clinical epidemiology. vol 76. 2017-07-03. PMID:27060386. |
a combined meta-analysis of n-of-1 trial data with rct data on amphetamines and methylphenidate for pediatric adhd. |
2017-07-03 |
2023-08-13 |
Not clear |
| b' Annie P Odell, Grace L Reynolds, Dennis G Fisher, Loucine M Huckabay, William C Pedersen, Pamela Xandre, Milica Mio\\xc4\\x8devi\\xc4\\x8. Attention Deficit Hyperactivity Disorder, Aggression, and Illicit Stimulant Use: Is This Self-Medication? The Journal of nervous and mental disease. vol 205. issue 5. 2017-04-28. PMID:28230564.' |
those with adhd were higher on all scales of the aq and daq, were younger at first use of amphetamines, and were more likely to have ever used crack and amphetamines. |
2017-04-28 |
2023-08-13 |
Not clear |
| Two new amphetamines for ADHD. The Medical letter on drugs and therapeutics. vol 58. issue 1497. 2017-01-30. PMID:27305069. |
two new amphetamines for adhd. |
2017-01-30 |
2023-08-13 |
Not clear |
| Ann Childress, Chau Tra. Current Investigational Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder. Expert opinion on investigational drugs. vol 25. issue 4. 2016-12-13. PMID:26814173. |
treatment for adhd has been available since bradley first prescribed amphetamines for hyperkinetic boys more than 70 years ago. |
2016-12-13 |
2023-08-13 |
Not clear |
| Salima Punja, Larissa Shamseer, Lisa Hartling, Liana Urichuk, Ben Vandermeer, Jane Nikles, Sunita Vohr. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. The Cochrane database of systematic reviews. vol 2. 2016-06-20. PMID:26844979. |
amphetamines for attention deficit hyperactivity disorder (adhd) in children and adolescents. |
2016-06-20 |
2023-08-13 |
Not clear |
| Salima Punja, Larissa Shamseer, Lisa Hartling, Liana Urichuk, Ben Vandermeer, Jane Nikles, Sunita Vohr. Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. The Cochrane database of systematic reviews. vol 2. 2016-06-20. PMID:26844979. |
amphetamines are among the most commonly prescribed medications to manage adhd. |
2016-06-20 |
2023-08-13 |
Not clear |
| Sadanobu Ushijim. [Differential Diagnosis of ADHD from Personality Disorders]. Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica. vol 117. issue 9. 2016-05-05. PMID:26721071. |
the author discussed some points regarding the process of differentially diagnosing adhd from antisocial personality disorder with antisocial behaviors, such as the use of amphetamines, theft, and violence, and borderline personality disorder with eating disorder, self-harming, overdose, and domestic violence. |
2016-05-05 |
2023-08-13 |
Not clear |
| Timothy E Albertson, James A Chenoweth, Daniel K Colby, Mark E Sutte. The Changing Drug Culture: Use and Misuse of Cognition-Enhancing Drugs. FP essentials. vol 441. 2016-05-03. PMID:26881770. |
there has been an increase in diagnoses of attention-deficit/hyperactivity disorder (adhd), with approximately 9% of american children now diagnosed, and a concomitant increase in the use of stimulants (eg, amphetamines, methylphenidate) to manage adhd. |
2016-05-03 |
2023-08-13 |
Not clear |
| William D Graf, Geoffrey Miller, Saskia K Nage. Addressing the problem of ADHD medication as neuroenhancements. Expert review of neurotherapeutics. vol 14. issue 5. 2014-12-01. PMID:24738763. |
adhd is closely linked to its treatment with medications such as methylphenidate and amphetamines, which have popular appeal as neuroenhancement drugs by persons without a neurological disorder. |
2014-12-01 |
2023-08-13 |
Not clear |
| Jessica Johansson, Magnus Landgren, Elisabeth Fernell, Tommy Lewander, Nikolaos Venizelo. Decreased binding capacity (Bmax) of muscarinic acetylcholine receptors in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD). Attention deficit and hyperactivity disorders. vol 5. issue 3. 2014-10-26. PMID:23389940. |
monoaminergic dysregulation is implicated in attention-deficit/hyperactivity disorder (adhd), and methylphenidate and amphetamines are the most frequently prescribed pharmacological agents for treating adhd. |
2014-10-26 |
2023-08-12 |
Not clear |
| Lisa L Weyandt, Danielle R Oster, Marisa E Marraccini, Bergljot Gyda Gudmundsdottir, Bailey A Munro, Brynheld Martinez Zavras, Ben Kuha. Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants. Psychology research and behavior management. vol 7. 2014-09-17. PMID:25228824. |
results revealed that both prostimulant and stimulant medications, including lisdexamfetamine dimesylate, methylphenidate, amphetamines, and mixed-amphetamine salts, are effective at reducing adhd symptoms in adolescents and adults with adhd. |
2014-09-17 |
2023-08-13 |
Not clear |
| Himanshu P Upadhyaya, Durisala Desaiah, Kory J Schuh, Frank P Bymaster, Mary J Kallman, David O Clarke, Todd M Durell, Paula T Trzepacz, David O Calligaro, Eric S Nisenbaum, Paul J Emmerson, Leslie M Schuh, Warren K Bickel, Albert J Alle. A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder. Psychopharmacology. vol 226. issue 2. 2013-09-10. PMID:23397050. |
treatment of attention-deficit/hyperactivity disorder (adhd) has for many years relied on psychostimulants, particularly various formulations of amphetamines and methylphenidate. |
2013-09-10 |
2023-08-12 |
Not clear |
| Joshua L Fenderson, Amy N Stratton, Jennifer S Domingo, Gerald O Matthews, Christopher D Ta. Amphetamine positive urine toxicology screen secondary to atomoxetine. Case reports in psychiatry. vol 2013. 2013-02-21. PMID:23424703. |
while stimulant treatments for adhd could certainly result in a positive result on urine screen for amphetamines, there have been no reports of false-positive results for amphetamines secondary to patients using atomoxetine. |
2013-02-21 |
2023-08-12 |
Not clear |
| Jan Frölich, Tobias Banaschewski, Rainer Spanagel, Manfred Döpfner, Gerd Lehmkuh. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie. vol 40. issue 5. 2012-12-04. PMID:22869222. |
[the medical treatment of attention deficit hyperactivity disorder (adhd) with amphetamines in children and adolescents]. |
2012-12-04 |
2023-08-12 |
Not clear |
| Jan Frölich, Tobias Banaschewski, Rainer Spanagel, Manfred Döpfner, Gerd Lehmkuh. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie. vol 40. issue 5. 2012-12-04. PMID:22869222. |
psychostimulants (methylphenidate and amphetamines) are the drugs of first choice in the pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder (adhd). |
2012-12-04 |
2023-08-12 |
Not clear |
| John D Franzen, Tony W Wilso. Amphetamines modulate prefrontal γ oscillations during attention processing. Neuroreport. vol 23. issue 12. 2012-11-23. PMID:22776904. |
in this study, we utilized magnetoencephalography to examine how amphetamines modulate high-frequency brain activity in adults with adhd. |
2012-11-23 |
2023-08-12 |
human |
| A G Franke, A Konrad, K Lieb, M Hus. [Stimulant and non-stimulant medication in current and future therapy for ADHD]. Fortschritte der Neurologie-Psychiatrie. vol 80. issue 3. 2012-07-11. PMID:21611939. |
the current pharmacotherapy for attention-deficit hyperactivity disorder (adhd) is mainly based on the stimulant methylphenidate and to a small extent on amphetamines which are not approved in germany. |
2012-07-11 |
2023-08-12 |
Not clear |
| Anjan S Batra, Mark E Alexander, Michael J Silk. Attention-deficit/hyperactivity disorder, stimulant therapy, and the patient with congenital heart disease: evidence and reason. Pediatric cardiology. vol 33. issue 3. 2012-06-26. PMID:22298228. |
stimulant medications, specifically methylphenidates and amphetamines, are frequently prescribed and effective in reducing the symptoms of adhd. |
2012-06-26 |
2023-08-12 |
Not clear |